基于報(bào)告基因檢測(cè)的PXR、FXR和LXRα激動(dòng)劑高通量篩選模型的建立
發(fā)布時(shí)間：2019-06-21 04:34
【摘要】：目的建立基于報(bào)告基因法的高通量篩選細(xì)胞模型,用來(lái)發(fā)現(xiàn)PXR、FXR和LXRα受體激動(dòng)劑。方法利用Real-time定量PCR方法比較HEK293、Hep G2和LS174T細(xì)胞中內(nèi)源性核受體PXR、FXR和LXRα的表達(dá)量,將p SG5-h PXR和p GL3-XREM-CYP3A4、p EGFP-N3-h FXR和EcRETK-Luc、p CMX-FLAG-h LXRα和p GL3-XREM-CYP3A4等質(zhì)粒分別共轉(zhuǎn)染到工具細(xì)胞中,優(yōu)化共轉(zhuǎn)染比例,并考察陽(yáng)性藥與螢光素酶報(bào)告基因表達(dá)強(qiáng)度的量效關(guān)系、模型特異性和穩(wěn)定性。結(jié)果 1根據(jù)Real-time定量PCR結(jié)果,模型選用低表達(dá)PXR、FXR和LXRα的HEK293細(xì)胞作為工具細(xì)胞;2根據(jù)不同共轉(zhuǎn)染比例對(duì)報(bào)告基因活性的結(jié)果,PXR、FXR和LXRα報(bào)告基因藥物篩選模型的報(bào)告基因和過(guò)表達(dá)質(zhì)粒比例,最終分別選擇1∶1、2∶1和2∶1;3模型中,報(bào)告基因活性均與相應(yīng)陽(yáng)性藥物(PXR/Rif、FXR/CDCA和LXRα/T0901317)呈劑量依賴性增長(zhǎng);4僅PXR激動(dòng)劑Rif、FXR激動(dòng)劑CDCA和LXRα激動(dòng)劑T0901317可分別明顯增加相應(yīng)篩選模型的報(bào)告基因活性,分別重復(fù)5次試驗(yàn)后,計(jì)算得Z'值分別為0.58、0.66和0.63。結(jié)論該研究建立的PXR、FXR和LXRα激動(dòng)劑高通量篩選模型,具有良好的特異性和穩(wěn)定性,適用于對(duì)PXR、FXR和LXRα受體激動(dòng)劑的篩選,進(jìn)而開(kāi)發(fā)以核受體作為藥物靶點(diǎn)的藥物。
[Abstract]:Objective to establish a high throughput screening cell model based on reporter gene method for the detection of PXR,FXR and LXR 偽 receptor agonists. Methods Real-time quantitative PCR was used to compare the expression of endogenous nuclear receptors PXR,FXR and LXR 偽 in HEK293,Hep G2 and LS174T cells. PSG5-h PXR and pGL3-XREM-CYP3A4,p EGFP-N3-h FXR and EcRETK-Luc,p CMX-FLAG-h LXR 偽 and pGL3-XREM-CYP3A4 were co-transfected into tool cells, respectively. The co-transfection ratio was optimized, and the dose-effect relationship between positive drugs and luciferase reporter gene expression intensity was investigated. Model specificity and stability. Results (1) according to the results of Real-time quantitative PCR, HEK293 cells with low expression of PXR,FXR and LXR 偽 were selected as tool cells, (2) the ratio of reporter gene and overexpression plasmid of PXR,FXR and LXR 偽 reporter gene drug screening model was 1: 1, 2: 1 and 2: 1, respectively, according to the results of reporter gene activity of PXR,FXR and LXR 偽 reporter gene screening model, and the ratio of reporter gene and overexpression plasmid of PXR,FXR and LXR 偽 reporter gene drug screening model was 1: 1, 2: 1 and 2: 1, respectively. 3 in the model, the reporter gene activity increased in a dose-dependent manner with the corresponding positive drugs (PXR/Rif,FXR/CDCA and LXR 偽 / T0901317). 4 only PXR agonist Rif,FXR agonist CDCA and LXR 偽 agonist T0901317 significantly increased the reporter gene activity of the corresponding screening model, and the calculated Z' values were 0.580.66 and 0.63, respectively. Conclusion the high throughput screening model of PXR,FXR and LXR 偽 agonists established by this study has good specificity and stability, and is suitable for screening PXR,FXR and LXR 偽 receptor agonists, and then develop drugs with nuclear receptors as drug targets.
【作者單位】： 中山大學(xué)藥學(xué)院藥物代謝與藥動(dòng)學(xué)實(shí)驗(yàn)室;
【基金】：廣東省新藥設(shè)計(jì)與評(píng)價(jià)重點(diǎn)實(shí)驗(yàn)室開(kāi)放基金(No 2011A060901014-009)
【分類(lèi)號(hào)】：R96
[Abstract]:Objective to establish a high throughput screening cell model based on reporter gene method for the detection of PXR,FXR and LXR 偽 receptor agonists. Methods Real-time quantitative PCR was used to compare the expression of endogenous nuclear receptors PXR,FXR and LXR 偽 in HEK293,Hep G2 and LS174T cells. PSG5-h PXR and pGL3-XREM-CYP3A4,p EGFP-N3-h FXR and EcRETK-Luc,p CMX-FLAG-h LXR 偽 and pGL3-XREM-CYP3A4 were co-transfected into tool cells, respectively. The co-transfection ratio was optimized, and the dose-effect relationship between positive drugs and luciferase reporter gene expression intensity was investigated. Model specificity and stability. Results (1) according to the results of Real-time quantitative PCR, HEK293 cells with low expression of PXR,FXR and LXR 偽 were selected as tool cells, (2) the ratio of reporter gene and overexpression plasmid of PXR,FXR and LXR 偽 reporter gene drug screening model was 1: 1, 2: 1 and 2: 1, respectively, according to the results of reporter gene activity of PXR,FXR and LXR 偽 reporter gene screening model, and the ratio of reporter gene and overexpression plasmid of PXR,FXR and LXR 偽 reporter gene drug screening model was 1: 1, 2: 1 and 2: 1, respectively. 3 in the model, the reporter gene activity increased in a dose-dependent manner with the corresponding positive drugs (PXR/Rif,FXR/CDCA and LXR 偽 / T0901317). 4 only PXR agonist Rif,FXR agonist CDCA and LXR 偽 agonist T0901317 significantly increased the reporter gene activity of the corresponding screening model, and the calculated Z' values were 0.580.66 and 0.63, respectively. Conclusion the high throughput screening model of PXR,FXR and LXR 偽 agonists established by this study has good specificity and stability, and is suitable for screening PXR,FXR and LXR 偽 receptor agonists, and then develop drugs with nuclear receptors as drug targets.
【作者單位】： 中山大學(xué)藥學(xué)院藥物代謝與藥動(dòng)學(xué)實(shí)驗(yàn)室;
【基金】：廣東省新藥設(shè)計(jì)與評(píng)價(jià)重點(diǎn)實(shí)驗(yàn)室開(kāi)放基金(No 2011A060901014-009)
【分類(lèi)號(hào)】：R96
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 薛麗香,童坦君,張宗玉;報(bào)告基因的選擇及其研究趨向[J];生理科學(xué)進(jìn)展;2002年04期
2 孫哲,呂秋軍,溫利青,郭紹明,陳媛媛,劉衛(wèi)京;基于報(bào)告基因的雌激素受體α亞型配體篩選模型的建立和應(yīng)用[J];藥學(xué)學(xué)報(bào);2000年10期
3 陳振花,呂秋軍,溫利青,葉棋濃,曹穎林,周俠;基于報(bào)告基因和干擾素-α信號(hào)通路的藥物篩選模型的建立[J];中國(guó)藥理學(xué)通報(bào);2005年02期
4 于西佼;李紓;;報(bào)告基因及其在生物膜研究中的應(yīng)用[J];國(guó)外醫(yī)學(xué).口腔醫(yī)學(xué)分冊(cè);2006年01期
5 張帆;盧光明;;報(bào)告基因信號(hào)擴(kuò)增方法的研究進(jìn)展[J];醫(yī)學(xué)研究生學(xué)報(bào);2008年10期
6 王勁茗;凌均h，
本文編號(hào)：2503791
本文鏈接：http://sikaile.net/yixuelunwen/yiyaoxuelunwen/2503791.html
最近更新
教材專(zhuān)著
